In parallel, reprogramming of cellular clock function in cancers is increasingly evident and the role of clock genes in the development of hematological tumors, as well as their pathophysiological effects on tissues distal to the tumor, has been described. The gene discussed is CLOCK; the disease is hematopoietic and lymphoid system neoplasm.